Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Antonio Sierra is active.

Publication


Featured researches published by Antonio Sierra.


Critical Care Medicine | 2005

Ventilator-associated pneumonia using a closed versus an open tracheal suction system.

Leonardo Lorente; María Lecuona; M Martín; C García; M Mora; Antonio Sierra

Objective:The aim of this study was to analyze the prevalence of ventilator-associated pneumonia (VAP) using a closed-tracheal suction system vs. an open system. Design:Prospective and randomized study, from October 1, 2002, to December 31, 2003. Setting:A 24-bed medical-surgical intensive care unit in a 650-bed tertiary hospital. Patients:Patients requiring mechanical ventilation for >24 hrs. Interventions:Patients were randomized into two groups; one group was suctioned with the closed-tracheal suctioning system and another group with the open system. Measurements:Throat swabs were taken at admission and twice a week until discharge to classify pneumonia in endogenous and exogenous. Main Results:A total of 443 patients (210 with closed-tracheal suction system and 233 with the open system) were included. There were no significant differences between groups of patients in age, sex, diagnosis groups, mortality, number of aspirations per day, and Acute Physiology and Chronic Health Evaluation II score. No significant differences were found in either the percentage of patients who developed VAP (20.47% vs. 18.02%) or in the number of VAP cases per 1000 mechanical ventilation-days (17.59 vs. 15.84). There were also no differences in the VAP incidence by mechanical ventilation duration. At the same time, we did not find any differences in the incidence of exogenous VAP. Likewise, there were also no differences in the microorganisms responsible for pneumonia. Patient cost per day for the closed suction was more expensive than the open suction system (


Critical Care | 2009

Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis

Leonardo Lorente; M Martín; Lorenzo Labarta; César Díaz; Jordi Solé-Violán; José Blanquer; Josune Orbe; José Antonio Piqueras Rodríguez; Alejandro Jiménez; Juan M. Borreguero-León; Felipe Belmonte; Juan C Medina; María C LLimiñana; José M Ferrer-Agüero; José Ferreres; M Mora; Santiago Lubillo; Manuel Fernández Sánchez; Ysamar Barrios; Antonio Sierra; José A. Páramo

11.11 ±


Intensive Care Medicine | 2006

Tracheal suction by closed system without daily change versus open system

Leonardo Lorente; María Lecuona; Alejandro Jiménez; M Mora; Antonio Sierra

2.25 vs.


Clinical Infectious Diseases | 2008

The Use of Rifampicin-Miconazole—Impregnated Catheters Reduces the Incidence of Femoral and Jugular Catheter-Related Bacteremia

Leonardo Lorente; María Lecuona; María José Ramos; Alejandro Jiménez; M Mora; Antonio Sierra

2.50 ±


Journal of Hospital Infection | 1999

Nosocomial infection, indices of intrinsic infection risk, and in-hospital mortality in general surgery.

Miguel Delgado-Rodríguez; A. Gomez-ortega; Javier Llorca; M. Lecuona; Trinidad Dierssen; M. Sillero-arenas; Antonio Sierra

1.12, p < .001). Conclusion:We conclude that in our study, the closed-tracheal suction system did not reduce VAP incidence, even for exogenous pneumonia.


European Journal of Clinical Microbiology & Infectious Diseases | 2012

Ventilator-associated pneumonia with or without toothbrushing: a randomized controlled trial

Leonardo Lorente; María Lecuona; A. Jiménez; S. Palmero; E. Pastor; N. Lafuente; María José Ramos; M Mora; Antonio Sierra

IntroductionMatrix metalloproteinases (MMPs) play a role in infectious diseases through extracellular matrix (ECM) degradation, which favors the migration of immune cells from the bloodstream to sites of inflammation. Although higher levels of MMP-9 and tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) have been found in small series of patients with sepsis, MMP-10 levels have not been studied in this setting. The objective of this study was to determine the predictive value of MMP-9, MMP-10, and TIMP-1 on clinical severity and mortality in a large series of patients with severe sepsis.MethodsThis was a multicenter, observational, and prospective study carried out in six Spanish Intensive Care Units. We included 192 (125 surviving and 67 nonsurviving) patients with severe sepsis and 50 age- and sex-matched healthy controls in the study. Serum levels of MMP-9, MMP-10, TIMP-1, tumor necrosis factor (TNF)-alpha, and interleukin (IL)-10 were measured in patients with severe sepsis at the time of diagnosis and in healthy controls.ResultsSepsis patients had higher levels of MMP-10 and TIMP-1, higher MMP-10/TIMP-1 ratios, and lower MMP-9/TIMP-1 ratios than did healthy controls (P < 0.001). An association was found between MMP-9, MMP-10, TIMP-1, and MMP-9/TIMP-1 ratios and parameters of sepsis severity, assessed by the SOFA score, the APACHE-II score, lactic acid, platelet count, and markers of coagulopathy. Nonsurviving sepsis patients had lower levels of MMP-9 (P = 0.037), higher levels of TIMP-1 (P < 0.001), lower MMP-9/TIMP-1 ratio (P = 0.003), higher levels of IL-10 (P < 0.001), and lower TNF-α/IL-10 ratio than did surviving patients. An association was found between MMP-9, MMP-10, and TIMP-1 levels, and TNF-α and IL-10 levels. The risk of death in sepsis patients with TIMP-1 values greater than 531 ng/ml was 80% higher than that in patients with lower values (RR = 1.80; 95% CI = 1.13 to 2.87;P = 0.01; sensitivity = 0.73; specificity = 0.45).ConclusionsThe novel findings of our study on patients with severe sepsis (to our knowledge, the largest series reporting data about MMP levels in sepsis) are that reduced MMP-9/TIMP-1 ratios and increased MMP-10 levels may be of great pathophysiologic significance in terms of severity and mortality, and that TIMP-1 levels may represent a biomarker to predict the clinical outcome of patients with sepsis.


Infection Control and Hospital Epidemiology | 2004

Periodically changing ventilator circuits is not necessary to prevent ventilator-associated pneumonia when a heat and moisture exchanger is used

Leonardo Lorente; María Lecuona; R Galván; María José Ramos; M Mora; Antonio Sierra

BackgroundTracheal suctioning costs are higher with a closed tracheal suction system (CTSS) than with an open system (OTSS), due to the need for complete daily change as recommended by the manufacturer. However, is it necessary to change the closed system daily?ObjectiveTo evaluate the tracheal suctioning costs and incidence of ventilator-associated pneumonia (VAP) using closed system without daily change vs OTSS.DesignProspective and randomised study.SettingAn Intensive Care Unit in a university hospital.PatientsPatients requiring mechanical ventilation.InterventionsPatients were randomly assigned to CTSS without daily change or OTSS. We used a CTSS that allowed partial or complete change.Measurements and resultsThere were no significant differences between both groups of patients (236 with CTSS and 221 with OTSS) in gender, age, diagnosis, APACHE-II score, mortality, number of aspirations per day, percentage of patients who developed VAP (13.9 vs 14.1%) or the number of ventilator-associated pneumonia per 1000 days of mechanical ventilation (14.1 vs 14.6). There were not significant differences in tracheal suctioning costs per patient/day between CTSS vs OTSS (2.3 ± 3.7 vs 2.4 ± 0.5 Euros; p = 0.96); however, when length of mechanical ventilation was lower than 4 days, the cost was higher with CTSS than with OTSS (7.2 ± 4.7 vs 1.9 ± 0.6 Euros; p < 0.001); and when length of mechanical ventilation was higher than 4 days, the cost was lower with CTSS than with OTSS (1.6 ± 2.8 vs 2.5 ± 0.5 Euros; p < 0.001).ConclusionCTSS without daily change is the optimal option for patients needing tracheal suction longer than 4 days.


Critical Care Medicine | 2003

Bacterial filters in respiratory circuits: an unnecessary cost?

Leonardo Lorente; María Lecuona; Javier Málaga; Consuelo Revert; M Mora; Antonio Sierra

BACKGROUND The guidelines of the Centers for Disease Control and Prevention do not recommend the use of an antimicrobial- or antiseptic-impregnated catheter for short-term use. In previous studies, we have found a higher incidence of central venous catheter-related bacteremia among patients with femoral and central jugular accesses than among patients with other venous accesses. OBJECTIVE The objective of our study was to determine the incidence of central venous catheter-related bacteremia associated with rifampicin-miconazole-impregnated catheters and standard catheters in patients with femoral and central jugular venous accesses. METHODS This was a cohort study, conducted in the 24-bed polyvalent medical-surgical intensive care unit of a university hospital. We included patients who were admitted to the intensive care unit from 1 June 2006 through 30 September 2007 and who underwent femoral or central jugular venous catheterization. RESULTS We inserted 184 femoral (73 rifampicin-miconazole-impregnated catheters and 111 standard catheters) and 241 central jugular venous catheters (114 rifampicin-miconazole-impregnated catheters and 127 standard catheters). We found a lower rate of central venous catheter-related bacteremia associated with rifampicin-miconazole-impregnated catheters than with standard catheters among patients with femoral access (0 vs. 8.62 cases per 1000 catheter-days; odds ratio, 0.13; 95% confidence interval, 0.00-0.86; P = .03) and among patients with central internal jugular access (0 vs. 4.93 cases per 1000 catheter-days; odds ratio, 0.13; 95% confidence interval, 0.00-0.93; P = .04). CONCLUSIONS Rifampicin-minonazole-impregnated catheters are associated with a statistically significant reduction in the incidence of catheter-related bacteremia in patients with short-term catheter use at the central jugular and femoral sites.


Journal of Hospital Infection | 1998

Risk factors for surgical site infections diagnosed after hospital discharge.

M. Lecuona; À. Torres-Lana; M. Delgado-Rodríguez; Javier Llorca; Antonio Sierra

The objectives of this paper are to assess whether two indices of intrinsic infection risk (the SENIC and the NNIS index) predict in-hospital mortality and the attributable in-hospital mortality due to nosocomial infection in surgical patients. A prospective study on 4714 patients admitted to three hospitals has been carried out. The relative risk and its 95% confidence interval (CI) were estimated. Multiple-risk factors adjusted for odds ratios (OR) were yielded by logistic regression analysis. Overall, 119 patients (2.5%) died before hospital discharge. Both the SENIC and the NNIS indices were related to in-hospital mortality in crude data. After controlling for several variables (age, sex, ASA score, cancer, renal failure, diabetes mellitus, stay at the ICU), the SENIC index did not show any significant trend with mortality (P = 0.252), whereas the trend was significant for the NNIS index (P < 0.001). Risk of death in patients with one nosocomial infection was 7.5%, and in patients developing more than one nosocomial infection was 17.1%. After adjusting for several confounding variables, the development of an organ/space surgical site infection was significantly related to mortality (OR = 4.5, 95% CI 1.5-15.6) as was blood infection (OR = 17.3, 95% CI 3.5-87.0). The association of a surgical site infection and either a respiratory tract infection or a blood infection also increased significantly the risk of in-hospital mortality (OR = 3.3, 95% CI 1.2-8.7). In conclusion, the NNIS index is a good predictor of in-hospital mortality. Patients developing an organ/space surgical site infection and/or a blood infection have an increased risk of in-hospital mortality.


Infection Control and Hospital Epidemiology | 2003

Epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital in the Canary Islands.

Isabel Montesinos; Eduardo Salido; Teresa Delgado; María Lecuona; Antonio Sierra

Certain guidelines for the prevention of ventilator-associated pneumonia (VAP) recommend oral care with chlorhexidine, but none refer to the use of a toothbrush for oral hygiene. The role of toothbrush use has received scant attention. Thus, the objective of this study was to compare the incidence of VAP in critical care patients receiving oral care with and without manual brushing of the teeth. This was a randomized clinical trial developed in a 24-bed medical-surgical intensive care unit (ICU). Patients undergoing invasive mechanical ventilation for than 24 h were included. Patients were randomly assigned to receive oral care with or without toothbrushing. All patients received oral care with 0.12 % chlorhexidine digluconate. Tracheal aspirate samples were obtained during endotracheal intubation, then twice a week, and, finally, on extubation. There were no significant differences between the two groups of patients in the baseline characteristics. We found no statistically significant differences between the groups regarding the incidence of VAP (21 of 217 [9.7 %] with toothbrushing vs. 24 of 219 [11.0 %] without toothbrushing; odds ratio [OR] = 0.87, 95 % confidence interval [CI] = 0.469–1.615; p = 0.75). Adding manual toothbrushing to chlorhexidine oral care does not help to prevent VAP in critical care patients on mechanical ventilation.

Collaboration


Dive into the Antonio Sierra's collaboration.

Top Co-Authors

Avatar

María Lecuona

Hospital Universitario de Canarias

View shared research outputs
Top Co-Authors

Avatar

M Mora

Hospital Universitario de Canarias

View shared research outputs
Top Co-Authors

Avatar

Leonardo Lorente

Hospital Universitario de Canarias

View shared research outputs
Top Co-Authors

Avatar

Alejandro Jiménez

Hospital Universitario de Canarias

View shared research outputs
Top Co-Authors

Avatar

María José Ramos

Hospital Universitario de Canarias

View shared research outputs
Top Co-Authors

Avatar

Isabel Montesinos

Hospital Universitario de Canarias

View shared research outputs
Top Co-Authors

Avatar

C García

Hospital Universitario de Canarias

View shared research outputs
Top Co-Authors

Avatar

R Galván

Hospital Universitario de Canarias

View shared research outputs
Top Co-Authors

Avatar

Teresa Delgado

Hospital Universitario de Canarias

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge